Links between gut dysbiosis and the onset of disease are continually being established with the hope that therapeutic interventions may be developed soon to halt disease progression. Now, investigators at the NYU School of Medicine, Perlmutter Cancer Center, and NYU College of Dentistry have just released data that describes how a population of bacteria in the pancreas increases more than a thousand-fold in patients with pancreatic cancer—becoming dominated by species that prevent the immune system from attacking tumor cells. Read more . . .
Understanding the appropriate balance of “good” bacteria within the intestinal tract has been the focus of much ongoing research for a number of years.